Sign in
4

Changes in Ownership

XBiotech Inc. Filed Acc 0000950170-25-013647

Options or other derivatives

  • Chief Executive Officer disposed of 2,470,355 shares (other)

From the SEC's structured data for this filing

Trades in this filing

SIMARD JOHN · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-01-31 Other disposition : show line 1 in the form Convertible Loan Agreement −2,470,355 $10,000,000.00 $24,703,550,000,000 870,381 D
Loading xslF345X05/ownership.xml…